Sign in

CIK 0002091349

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

First Tracks Biotherapeutics, Inc.

Sign in to watch
Ticker
TRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
395003207
Phone
+1 212-373-3000
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
Biopharma Company, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,145
in 1 filing

Net −$1,758,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ware J. Anthony −$1.8M Director sold 71% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-01 STONE BENJAMIN Chief Business Officer Grant or award · Common Stock +42,500 42,500
2026-11-01 Tamboli Ajim Chief Financial Officer Grant or award · Common Stock +42,500 42,500
2026-11-01 Lizzul Paul F. Chief Medical Officer Grant or award · Common Stock +42,500 42,500
2026-11-01 Faga Daniel President, CEO Grant or award · Common Stock +136,000 136,000
2026-09-15 Orwin John A Director Exercise or conversion +1,300 17,995
2026-09-15 Orwin John A Director Exercise or conversion · Restricted Stock Unit −1,300 0
2026-09-02 Ware J. Anthony Director Exercise or conversion +39,265 $5.74 $225K 54,925
2026-09-02 Ware J. Anthony Director Sale −39,265 $44.78 $1.8M 15,660
2026-09-02 Ware J. Anthony Director Exercise or conversion · Stock Option (right to buy) −28,571 0
2026-09-02 Ware J. Anthony Director Exercise or conversion · Stock Option (right to buy) −10,694 0
2026-08-15 STONE BENJAMIN Chief Business Officer Grant or award · Performance Stock Units +60,492 137,651
2026-08-15 Lizzul Paul F. Chief Medical Officer Grant or award · Performance Stock Units +60,492 137,651
2026-08-15 Faga Daniel President, CEO Grant or award · Performance Stock Units +193,575 440,485
2026-08-02 STONE BENJAMIN Chief Business Officer Grant or award · Performance Stock Units +60,492 77,159
2026-08-02 Lizzul Paul F. Chief Medical Officer Grant or award · Performance Stock Units +60,492 77,159
2026-08-02 Faga Daniel President, CEO Grant or award · Performance Stock Units +193,576 387,156
2026-06-15 Ware J. Anthony Director Exercise or conversion +6,030 15,660
2026-06-15 Ware J. Anthony Director Exercise or conversion · Restricted Stock Unit −6,030 0
2026-06-15 Jain Rita Director Exercise or conversion +7,330 19,194
2026-06-15 Jain Rita Director Exercise or conversion · Restricted Stock Unit −6,030 0

Page 1 of 8 · 151 trades